跳至主要内容
临床试验/EUCTR2013-001416-30-ES
EUCTR2013-001416-30-ES进行中(未招募)1 期

?Multicenter study of a single arm to evaluate the safety of eribulin in 3rd line chemotherapy for patients with HER2-negative metastatic or locally advanced previously treated with anthracyclines and taxanes: Onsite Study - ONCOSUR-2012-02

Fundación Oncosur0 个研究点目标入组 60 人开始时间: 2013年9月5日最近更新:
适应症
相关药物

试验速览

阶段
1 期
状态
进行中(未招募)
发起方
入组人数
60

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 60
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range 60

排除标准

  • 未提供

研究者

发起方
Fundación Oncosur

相似试验

招募中
1 期
To evaluate the safety tolerability and performance of the liver assist device (EBDLR System) in patients suffering from Acute Liver Failure
CTRI/2024/02/062612Ykrita Life sciences Pvt Ltd.
已完成
不适用
Reduction of contrast induced nephropathy (CIN) in patients requiring a percutaneous coronary intervention procedure and have chronic renal failure.Cardiovascular disease in patients with chronic kidney disease.Renal and Urogenital - Kidney diseaseCardiovascular - Diseases of the vasculature and circulation including the lymphatic system
ACTRN12612000238875Osprey Medical Pty Ltd42
进行中(未招募)
1 期
A clinical study, conducted in several sites in Belgium, investigating the administration at patient's home of the new subcutaneous formulation of the drug trastuzumab for treating patients suffering from a type of breast cancer at early stage, called HER2-positive early breast cancer.TO INVESTIGATE THE AT HOME ADMINISTRTATION OF TRASTUZUMAB SUBCUTANEOUS VIAL FOR THE TREATMENT OF PATIENTS WITH HER2-POSITIVE EARLY BREAST CANCER.
EUCTR2013-000123-13-BEV ROCHE SA100
招募中
3 期
A study to investigate the pharmacokinetics and safety of dupilumab in participants >=2 years to < 12 years of age with uncontrolled chronic spontaneous urticaria (CSU) or chronic inducible cold urticaria (CICU)
JPRN-jRCT2031220733Tanaka Tomoyuki24
已完成
不适用
Prospective Multi-Center, Single Arm Study of the Shockwave Coronary Rx Lithoplasty® System in Coronary Arteriesarterial stenosisstenotic coronary arteries10011082
NL-OMON43455Shockwave Medical Inc.15